Antibacterial properties and carbonic anhydrase inhibition profiles of azido sulfonyl carbamate derivatives.

The aim of this study was to identify inhibition of carbonic anhydrase I and II (CA I and II) isozymes by azido sulfonyl carbamates through both and approaches and also to determine the drug-likeness properties and antibacterial activities of azido sulfonyl carbamates. inhibition and molecular docking studies of azido sulfonyl carbamate derivatives () on isozymes were performed. Except for derivative , all derivatives inhibited human CA I and II. Almost all compounds had antibacterial effects. The docking results showed that compound had the best results, with binding energy of -8.20 kcal/mol for human CA I and -8.24 kcal/mol for human CA II. Molecule inhibited only CA I. Its usage as a potential chemotherapeutic agent specific to the CA I isozyme may be considered.